Femara® (Letrozole) | 1l Treatment For Hr+ Metastatic Breast Cancer Websites

- femara.com

Discover FEMARA® (letrozole), an approved treatment from Novartis Oncology for HR+ breast cancer in postmenopausal women. Learn about FEMARA® side effects & see recommended FEMARA® dosage information.

Not Applicable $ 8.95